论文部分内容阅读
目的:探讨“复合蛋白质粉”替代人血白蛋白治疗肝硬化腹水的临床研究。方法:将72例肝硬化腹水患者随机分为两组,治疗组37例,采用“复合蛋白质粉”(北京宝健牌)、苦参碱、利尿剂及对症治疗;对照组35例,采用人血白蛋白、苦参碱、利尿剂及对症治疗,疗程2周。结果:治疗组在腹水量、血清蛋白量方面均等同于对照组,两者无统计学差异(P>0.05)。结论:“复合蛋白质粉”替代人血白蛋白治疗肝硬化腹水有效。
Objective: To investigate the clinical research of “composite protein powder” substitute for human serum albumin in the treatment of ascites due to cirrhosis. Methods: Seventy-two cases of cirrhotic patients with ascites were randomly divided into two groups. The treatment group (n = 37) was treated with “composite protein powder” (Beijing Baojian), matrine, diuretic and symptomatic treatment. Human serum albumin, matrine, diuretics and symptomatic treatment, treatment for 2 weeks. Results: There was no significant difference between the two groups in the amount of ascites and serum protein in the treatment group (P> 0.05). Conclusion: The “composite protein powder” is an effective substitute for human serum albumin in the treatment of cirrhosis and ascites.